*Corresponding author:
krishnasarma pathy, Head /QC/QAIPL research centre, Editoral Board Member- Associate Editor, IndiaReceived: August 21, 2018; Published: August 29, 2018
DOI: 10.26717/BJSTR.2018.08.001662
To view the Full Article Peer-reviewed Article PDF
Practical Considerations in Pharmaceutical Production Scale-Up- This paper is meant to provide a high-level overview of the steps required to prepare the bulk drug substance API. From first-in-human and through each of the clinical trial stages and into commercialization, scale-up of formulation design is a natural part of pharmaceutical development. At each stage of process development, the batch size increases, from laboratory-scale batches that may be quite small to support preclinical and early clinical stages, to pilot batches that are used in process development, and finally to the production-scale batches needed to support commercialization.
Abstract | Introduction | Conclusion | References |
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China
Lecturer at the School of Energy and Chemical Engineering, Xiamen University Malaysia, Malaysia